JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

about

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

Item

http://www.wikidata.org/entity/Q55269538

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

@en

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

@nl

type

Item

label

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

@en

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

@nl

prefLabel

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

@en

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

@nl

P1476

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

@en

P2093

Ayako Suzuki

http://www.w3.org/2001/XMLSchema#string

Hiroaki Soyama

http://www.w3.org/2001/XMLSchema#string

Hitoshi Tsuda

http://www.w3.org/2001/XMLSchema#string

Isao Nagaoka

http://www.w3.org/2001/XMLSchema#string

Junko Hirata

http://www.w3.org/2001/XMLSchema#string

Kenichi Furuya

http://www.w3.org/2001/XMLSchema#string

Masashi Takano

http://www.w3.org/2001/XMLSchema#string

Morikazu Miyamoto

http://www.w3.org/2001/XMLSchema#string

Tadashi Aoyama

http://www.w3.org/2001/XMLSchema#string

Tomoko Goto

http://www.w3.org/2001/XMLSchema#string

P2860

Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?

Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells

Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infection with nitazoxanide

The STATs of cancer--new molecular targets come of age

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.

The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling.

The biology of ovarian cancer: new opportunities for translation

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer.

Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.

P304

5772-5780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8028

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29545902

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5840758

http://www.w3.org/2001/XMLSchema#string